|PURPLE-K Wins Creatine of the Year Award; Positioning Sire Bioscience Inc. for the Onset of Cannabis Health Products (CHP) Regulations|
|TORONTO, Ontario, May 11, 2020 – Still riding the excitement of its recent acquisition of Fusion Nutrition Inc, Sire Bioscience Inc. (CSE:SIRE) (OTC:BLLXF) (FSE:BR1B) (“SIRE” or the “Company”) announced that PURPLE-K has been awarded the Gold Award for Creatine of the Year by Popeyes Supplements Canada, the nation’s largest sport nutrition retailer. This prestigious award is based on performance in the following areas:
1. Sales2. Consumer demand3. Popularity and success of marketing over different social platforms4. Posts by end-users found on Instagram
The award also confirms that PURPLE-K – a premium creatine supplement designed to increase explosive strength – continues to grow in popularity. While it was originally developed for serious bodybuilders, its appeal has extended to more mainstream athletes and fitness enthusiasts. Similarly, the entire Fusion range is seeing steady growth across multiple consumer segments.
“PURPLE-K is a product I have personally used in my fitness endeavours and it’s an absolute honour to have within our House of Brands,” said Brian Polla, SIRE CEO. “It also greatly positions us for the onset of Cannabis Health Products [CHP] regulations. Can you imagine a top selling creatine like PUPRLE-K infused with CBD? We can!”
Subject to receiving CHP designation from Health Canada, SIRE will look to expand into food, drug, and mass market with a line of cannabinoid-infused sports supplements. SIRE believes that these products may harness the potential of CBD to support bodybuilders, athletes, and fitness enthusiasts with performance, pain management, and post-exercise recovery.
This line will also strengthen SIRE’s ‘House of Brands’ portfolio – offering people a wide range of unique, highly customized products to meet their individual needs.
About Fusion Nutrition Inc.Website: fusionmuscle.comSocials: @fusionmuscle
About Sire Bioscience Inc. SIRE’s principal business activity is to engage in the investment, production of, development of hemp and CBD and non-CBD products. SIRE has its wholly owned facility in Leamington, Ontario. The land parcel includes 50 acres of prime horticultural land, with a 160,000 sq. ft. facility of combined greenhouse and indoor space. SIRE’s goal is to become a vertically integrated CPG life science company with its “House of Brands” offering.
The CSE and Information Service Provider have not reviewed and does not accept responsibility for the accuracy or adequacy of this release.